Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies.

de Jonge JC, Vinkers CH, Hulshoff Pol HE, Marsman A.

Front Psychiatry. 2017 Aug 11;8:118. doi: 10.3389/fpsyt.2017.00118. eCollection 2017. Review.

2.

Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Sakata K, Overacre AE.

J Neurochem. 2017 Oct;143(1):49-64. doi: 10.1111/jnc.14129. Epub 2017 Aug 16.

3.
4.

Diagnostic Accuracy of Brain-derived Neurotrophic Factor and Nitric Oxide in Patients with Schizophrenia: A pilot study.

Djordjević VV, Lazarević D, Ćosić V, Knežević MZ, Djordjević VB, Stojanović I.

J Med Biochem. 2016 Jan;35(1):7-16. doi: 10.1515/jomb-2015-0010. Epub 2015 Dec 30.

5.

Dysbindin Deficiency Modifies the Expression of GABA Neuron and Ion Permeation Transcripts in the Developing Hippocampus.

Larimore J, Zlatic SA, Arnold M, Singleton KS, Cross R, Rudolph H, Bruegge MV, Sweetman A, Garza C, Whisnant E, Faundez V.

Front Genet. 2017 Mar 10;8:28. doi: 10.3389/fgene.2017.00028. eCollection 2017.

6.

Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies.

Tejeda GS, Díaz-Guerra M.

Int J Mol Sci. 2017 Jan 28;18(2). pii: E268. doi: 10.3390/ijms18020268. Review.

7.

GAD1 Gene Expression in Blood of Patients with First-Episode Psychosis.

Yee JY, Nurjono M, Teo SR, Lee TS, Lee J.

PLoS One. 2017 Jan 25;12(1):e0170805. doi: 10.1371/journal.pone.0170805. eCollection 2017.

8.

Neurotrophin signalling: novel insights into mechanisms and pathophysiology.

Mitre M, Mariga A, Chao MV.

Clin Sci (Lond). 2017 Jan 1;131(1):13-23. Review.

9.

The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders.

Cattaneo A, Cattane N, Begni V, Pariante CM, Riva MA.

Transl Psychiatry. 2016 Nov 22;6(11):e958. doi: 10.1038/tp.2016.214. Review.

11.

The Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-Analysis.

Sanada K, Zorrilla I, Iwata Y, Bermúdez-Ampudia C, Graff-Guerrero A, Martínez-Cengotitabengoa M, González-Pinto A.

Int J Mol Sci. 2016 Oct 24;17(10). pii: E1766. Review.

12.

Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.

Datta D, Arion D, Roman KM, Volk DW, Lewis DA.

Am J Psychiatry. 2017 Feb 1;174(2):163-171. doi: 10.1176/appi.ajp.2016.16020204. Epub 2016 Aug 13.

PMID:
27523502
13.

A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Malt EA, Juhasz K, Malt UF, Naumann T.

Front Behav Neurosci. 2016 Mar 30;10:59. doi: 10.3389/fnbeh.2016.00059. eCollection 2016.

14.

Calbindin Knockout Alters Sex-Specific Regulation of Behavior and Gene Expression in Amygdala and Prefrontal Cortex.

Harris EP, Abel JM, Tejada LD, Rissman EF.

Endocrinology. 2016 May;157(5):1967-79. doi: 10.1210/en.2016-1055. Epub 2016 Mar 24.

15.

Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons.

Georgiev D, Yoshihara T, Kawabata R, Matsubara T, Tsubomoto M, Minabe Y, Lewis DA, Hashimoto T.

Schizophr Bull. 2016 Jul;42(4):992-1002. doi: 10.1093/schbul/sbw022. Epub 2016 Mar 15.

16.

Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders.

Zanardini R, Ciani M, Benussi L, Ghidoni R.

Front Aging Neurosci. 2016 Feb 1;8:10. doi: 10.3389/fnagi.2016.00010. eCollection 2016. Review.

17.

Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons.

Canetta S, Bolkan S, Padilla-Coreano N, Song LJ, Sahn R, Harrison NL, Gordon JA, Brown A, Kellendonk C.

Mol Psychiatry. 2016 Jul;21(7):956-68. doi: 10.1038/mp.2015.222. Epub 2016 Feb 2.

18.

BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine.

Manning EE, Halberstadt AL, van den Buuse M.

Int J Neuropsychopharmacol. 2016 Apr 20;19(4). pii: pyv116. doi: 10.1093/ijnp/pyv116. Print 2016 Apr.

19.

Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia.

Kimoto S, Glausier JR, Fish KN, Volk DW, Bazmi HH, Arion D, Datta D, Lewis DA.

Schizophr Bull. 2016 Mar;42(2):396-405. doi: 10.1093/schbul/sbv139. Epub 2015 Sep 30.

20.

Supplemental Content

Support Center